Loading...
935106861
info@markelab.com
Precio
412.5€ (100 µg)
Elipovimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting HIV-1 gp120, Elipovimab (formerly GS-9722;PGT121-derived broadly neutralizing antibody).
Biosimilars
Human
Monoclonal
Human
HIV-1 gp120
Human
IgG1 Lambda
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 2101210-43-7
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más